If, as an example, we report the cumulative incidences in female path_MLH1 carriers at 75 years, the cumulative incidences of colon and rectal cancer were 46.2% and 7.4%, respectively (the sum being 53.6%), but the cumulative incidence for colon or rectal cancer was 48.3%. This evidence concerns the gene MLH1 and rectal cancer.